Balyasny Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,024,139
| Closed | -$15.3M | – | 2371 |
|
|
2023
Q3 | $15.3M | Sell |
1,024,139
-690,679
| -40% | -$10.3M | 0.03% | 513 |
|
|
2023
Q2 | $18.8M | Sell |
1,714,818
-242,250
| -12% | -$2.65M | 0.04% | 452 |
|
|
2023
Q1 | $17.1M | Buy |
1,957,068
+1,901,769
| +3,439% | +$16.6M | 0.04% | 463 |
|
|
2022
Q4 | $347K | Buy |
+55,299
| New | +$347K | ﹤0.01% | 1523 |
|
|
2019
Q3 | – | Sell |
-80,264
| Closed | -$575K | – | 1520 |
|
|
2019
Q2 | $575K | Buy |
80,264
+27,017
| +51% | +$194K | ﹤0.01% | 1062 |
|
|
2019
Q1 | $707K | Sell |
53,247
-190,819
| -78% | -$2.53M | ﹤0.01% | 1005 |
|
|
2018
Q4 | $1.92M | Buy |
+244,066
| New | +$1.92M | 0.01% | 643 |
|
|
2015
Q4 | – | Sell |
-12,600
| Closed | -$24K | – | 1332 |
|
|
2015
Q3 | $24K | Sell |
12,600
-1,715
| -12% | -$3.27K | ﹤0.01% | 942 |
|
|
2015
Q2 | $39K | Buy |
+14,315
| New | +$39K | ﹤0.01% | 875 |
|